# Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) Conditions

> **NCT01155908** · PHASE1 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Amlodipine Besylate / Benazepril Hydrochloride

## Key facts

- **NCT ID:** NCT01155908
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2010-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01155908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01155908, "Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) Conditions". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01155908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*